Safety, Immunogenicity and Efficacy of Modified Vaccinia Ankara (MVA) Against Dryvax(®) Challenge in Vaccinia-Naïve and Vaccinia-Immune Individuals

Modified vaccinia Ankara (MVA) was evaluated as an alternative to Dryvax(®) in vaccinia-naïve and immune adult volunteers. Subjects received intramuscular MVA or placebo followed by Dryvax(®) challenge at 3 months. Two or more doses of MVA prior to Dryvax(®) reduced severity of lesion formation, dec...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Parrino, Janie, McCurdy, Lewis H., Larkin, Brenda D., Gordon, Ingelise J., Rucker, Steven E., Enama, Mary E., Koup, Richard A., Roederer, Mario, Bailer, Robert T., Moodie, Zoe, Gu, Lin, Yan, Lihan, Graham, Barney S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2006
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1892755/
https://ncbi.nlm.nih.gov/pubmed/17126963
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2006.10.04
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados